Navigation

Product search

Language

Share

Test Kits Manufacturers

Home / Product / Colloidal Gold / LH Ovulation Rapid Test
  • LH Ovulation Rapid Test
  • LH Ovulation Rapid Test

LH Ovulation Rapid Test

Usage
The LH Ovulation Rapid Test is a rapid lateral flow chromatographic immunoassay for the qualitative detection of luteinizing hormone (LH) in urine to predict time of ovulation.

 

Background of Clinical Indications

Ovulation is the release of an egg from the ovary. The egg then passes into the fallopian tube where it is ready to be fertilized. In order for pregnancy to occur, the egg must be fertilized by sperm within 24 hours after its release. Immediately prior to ovulation, the body produces a large amount of luteinizing hormone (LH) which triggers the release of a ripened egg from the ovary. This “LH surge” usually takes place in the middle of the menstrual cycle.1 The LH Ovulation Rapid Test is a complete system to aid to predict the time of ovulation, and peak fertility. It is during this fertile time that pregnancy is most likely to occur. The test detects the LH surge in urine, signaling that ovulation is likely to occur in the next 24-36 hours, however, the LH surge and ovulation may not occur in all menstrual cycles. The LH Ovulation Rapid Test utilizes a combination of antibodies including a monoclonal LH antibody to selectively detect elevated levels of LH when the concentration of LH is equal to or greater than 25 mIU/mL.

Contact Us    PDF Download    

Packing specification

Principle of Inspection

The LH Ovulation Rapid Test is a membrane-based immunoassay for the qualitative detection of LH in human urine specimens. During testing, urine specimens is added to the sample pad to allowed to migrate through the absorbent test strip. The labelled antibody-dye conjugate binds to the LH in the specimen forming an antibody-antigen complex. This complex binds to the anti-LH antibody in the test line region (T) and produces a colored line. In the absence of LH, there is no colored line in the test line region (T). The reaction mixture continues flowing through the absorbent device past the test line region (T) and control line region (C). Unbound conjugate binds to the reagents in the control line region (C), producing a colored line, which works as the internal quality control of the assay, indicating that the test is functional, and proper and sufficient volume of specimen has been applied to enable migration through the test and control line, regardless of whether there is a test line or not. If the control line (C) does not appear within the testing time, test result is invalid and the test should be repeated with a new test device.

Specification packaging

25 Tests/Kit, 40 Tests/Kit.

Feedback

About Kangte

Zhejiang Kangte Biotechnology Co., Ltd

Zhejiang Kangte Biotechnology Co., Ltd. was established in 2001 and is located in Zhejiang Xinchang Provincial High-tech Industrial Park. It is a national high-tech enterprise integrating R&D, production and sales of in vitro diagnostic reagents. Relying on the pioneering team spirit and scientific management, the company has repeatedly won the national advanced production unit in the in vitro diagnostic industry. 

The company has GMP standard workshops, clean workshops, R&D laboratories, equipped with high-precision testing equipment and fully automatic production equipment. In order to enhance the company's overall R&D strength, it has established a good "production-study-research" cooperative relationship with many colleges and universities. The company has obtained a number of invention patents and utility model patents and has passed ISO9001, ISO14001, ISO13485, and other system certifications. The company currently has more than 100 registered products, covering biochemical, immunological, and other fields, and many of the products have reached the leading domestic level in technology. 

The company adheres to the concept of "integrity, professionalism, efficiency and innovation" to serve customers, and constantly introduces products with higher technological content to provide customers. The company will, as always, position itself in "service technology, professionalism and efficiency, and achieve customers", and work hard to jointly shape the IVD industry and continuously improve the level of human health.

 

  • 0+

    Registered products

  • 0+

    Cooperative Hospital

  • 0+

    Researchers

  • 0+

    Certificates

  • 0years+

    Working experience

News